Amantadine treatment and delayed onset of levodopa-induced dyskinesia in patients with early Parkinson's disease.

Early treatment with amantadine may delay LID onset more than treatment with other symptomatic agents. Further studies are needed to elucidate the mechanism of amantadine in LID onset delay and to validate our findings.